Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Outer membrane protein A (OmpA) is a predominant and highly conserved protein located in the outer membrane of Gram-negative bacteria, such as Escherichia coli, Acinetobacter baumannii, and Klebsiella pneumoniae (UniProt P0A910). It serves a critical structural role by anchoring the outer membrane to the underlying peptidoglycan layer through its C-terminal domain, thereby maintaining the mechanical integrity of the bacterial cell envelope (PubMed: 12730179). OmpA also functions as a multifaceted virulence factor, facilitating bacterial adhesion to host epithelial and endothelial cells, promoting biofilm formation, and contributing to resistance against host immune defenses like the complement system (PubMed: 25691586). In clinical contexts, OmpA is implicated in the pathogenesis of neonatal meningitis, pneumonia, and sepsis, making it a high-priority target for the development of next-generation antibacterial agents. Current therapeutic research focuses on utilizing OmpA as a vaccine antigen to elicit protective immunity or developing small molecules and monoclonal antibodies that inhibit its adhesive and structural functions (PubMed: 30254114). Additionally, OmpA acts as a receptor for various bacteriophages and colicins, highlighting its importance in bacterial ecology and competition (PubMed: 10411745).
Disruption of outer membrane integrity, inhibition of bacterial adhesion to host cells, and induction of protective immune responses through antigenic recognition.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Outer membrane protein A (OmpA).